CompletedPhase 1NCT00506259
Treatment Strategies for Children With Smith-Magenis Syndrome
Studying Smith-Magenis syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- William A Gahl, M.D.National Human Genome Research Institute (NHGRI)
- Intervention
- dTR Melatonin (NIH CC PDS)(drug)
- Enrollment
- 23 enrolled
- Eligibility
- 3-45 years · All sexes
- Timeline
- 2007 – 2018
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00506259 on ClinicalTrials.govOther trials for Smith-Magenis syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05116904Smith Magenis Syndrome and Autism Spectrum DisordersHospices Civils de Lyon
- RECRUITINGNCT03154697Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep DisturbancesVanda Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT00013559Natural History Study of Smith-Magenis SyndromeNational Human Genome Research Institute (NHGRI)